The Greatest Opportunities to Enhance Drug Development in 2025
The pharma industry continues to persevere through talent shortages, supply chain disruptions, data challenges, and many more obstacles that are making it increasingly difficult to get life-saving treatments to patients. However, the thirst for innovation and drive to make a difference for patients around the world is what keeps this sector going. As we start […]
Assessing AI Transformation in Pharma R&D: Current and Future Impact
Artificial intelligence (AI) has been one of the largest disruptors in drug development over the past few years, with the promise of innovation and greater efficiencies keeping the pharma industry heavily invested. There have been major advancements in AI-discovered molecules and AI-powered platforms for decentralized treatment, in addition to many more AI applications that have […]
The Current & Future Impact of AI on Pharmaceutical R&D
Artificial intelligence (AI) continues to disrupt existing paradigms in drug development, with early adopters experiencing both the benefits and challenges of this innovative technology. With that in mind, Norstella surveyed 125 senior decision-makers in the life sciences industry on their perceptions and expectations of AI to understand current AI adoption trends in addition to the […]
How Norstella is Embedding Artificial Intelligence to Improve Pipeline to Patient Decision-Making
In this white paper, Norstella describes its vision for the integration of artificial intelligence with its industry-leading data and advisory services. At each step from pipeline to patient, Norstella is embedding AI to create the next generation of solutions. These will help biopharma professionals to better contextualize their challenges, predict how scenarios will play out, […]
